North Carolina health officials confirmed two West Nile virus deaths among adults in the central part of the state, where CDC data show 11 human cases this season.
|Articles|January 25, 2020
The ID Pipeline: FDA Activity From the Week of January 19, 2020
Author(s)Contagion® Editorial Staff
Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of January 19, 2020.
Advertisement
Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of January 19, 2020.
NIAID Launches Clinical Trial to Test Long-Acting Combination HIV Treatment
The National Institute of Allergy and Infectious Diseases (NIAID) is launching a Phase 2 clinical trial of long-acting cabotegravir in combination with the HIV antibody VRC07-523LS.
The investigators of the trial are studying whether the combination is tolerable and prevents HIV from rebounding to detectable levels among those who previously kept the virus suppressed with daily antiretroviral treatment.
Read the
LexaGene Holdings Pathogen and Antibiotic Resistance Tests Achieve 100% Concordance
LexaGene Holdings has announced an expansion of its validated tests for antibiotic resistance. The company has completed testing of different superbug isolates provided by the US Centers for Disease Control and Prevention.
LexaGene’s automated, molecular based diagnostics were tested against antibiotic-resistant pathogens and the tests detected 100% of targeted genetic sequences. The study was broken into 2 parts, pathogen identification and antibiotic resistance detection.
Read the
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
SubscribeAdvertisement
Related to this article
A 39-year-old unvaccinated Franklin County woman has died after a recent measles diagnosis. Nationally, numbers continue to increase and the US has passed 4,000 cases.
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Detection of the virulent neurotropic fungus Cladophialophora bantiana in clinical samples, primarily CNS tissue, increased four-fold in the period from 2023 to 2025.
CDC reports 8,750 confirmed Bundibugyo virus cases and 4,208 deaths, making the DRC outbreak the second-largest Ebola outbreak on record.
Pritelivir (Hovilpri) healed all lesions by day 28 in 63% of immunocompromised adults with refractory HSV versus 34% with investigator's choice in the phase 3 PRIOH-1 trial.
CDC is continuing its investigation into 4 multistate Salmonella and E coli outbreaks, led by a 76-case alfalfa sprout cluster across 16 states and a recalled raw milk cheese.
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
Advertisement
Advertisement